Jeffrey V. Poulton

Jeffrey V. Poulton

Executive Vice President, Chief Financial Officer (principal financial officer)atAlnylam Pharmaceuticals· In proxies 2021–2025

Pay in FY2025+81% from the year before · Alnylam Pharmaceuticals stock +69.0% the same year

Jeffrey V. Poulton was paid $6.9M in FY2025 (Dec), up 81%. Alnylam Pharmaceuticals stock rose 69.0% that year.

Pay$100 in the stock at the end of FY20 → $306
Pay is from the Summary Compensation Table of each Alnylam Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Alnylam PharmaceuticalsPublic company · 5 yr
    • Executive Vice President, Chief Financial Officer (principal financial officer)2021 – Present · 5 yrStock in role +69%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?